← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$206K

Shares

13,712

Price

$15

Filed

Aug 15

Insider

Name

Allan Jonathan

Title

GENERAL COUNSEL & CORP SEC

CIK

0001966716

Roles

Officer

Transaction Details

Transaction Date

2025-08-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

19,631

Footnotes

This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024. | The reported total includes an aggregate 1,778 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d).

Filing Info

Accession No.

0001415889-25-022074

Form Type

4

Issuer CIK

0001623526

Allan Jonathan's History

Date Ticker Type Value
2026-03-20 STOK $292K
2026-03-20 STOK $21K
2025-12-08 STOK $41K
2025-12-08 STOK $87K
2025-12-05 STOK $31K
2025-12-05 STOK $169K
2025-12-05 STOK $74K
2025-12-04 STOK $25K
2025-12-04 STOK $6K
2025-12-03 STOK $27K

Other Insiders at STOK (90d)

Insider Bought Sold Last
Ticho Barry
CHIEF MEDICAL OFFICER
$60K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$313K 2026-03-20